These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 13921293)

  • 1. Antagonists of purine and pyrimidine metabolites and of folic acid.
    TIMMIS GM
    Adv Cancer Res; 1961; 6():369-401. PubMed ID: 13921293
    [No Abstract]   [Full Text] [Related]  

  • 2. Symposium on the experimental pharmacology and clinical use of antimetabolites. IX. The pyrimidine and purine antagonists.
    BURCHENAL JH; ELLISON RR
    Clin Pharmacol Ther; 1961; 2():523-41. PubMed ID: 13688926
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antimetabolites].
    Lansiaux A
    Bull Cancer; 2011 Nov; 98(11):1263-74. PubMed ID: 22049385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine and pyrimidine antagonists.
    HITCHINGS GH
    Am J Clin Nutr; 1955; 3(4):321-7. PubMed ID: 14398649
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of antimetabolites on the growth of Endamoeba histolytica. I. Purine and pyrimidine analogs.
    JONSSON S; NAKAMURA M
    Arch Biochem Biophys; 1957 Jan; 66(1):183-9. PubMed ID: 13395538
    [No Abstract]   [Full Text] [Related]  

  • 6. Potent inhibitors of de novo pyrimidine and purine biosynthesis as chemotherapeutic agents.
    Christopherson RI; Lyons SD
    Med Res Rev; 1990; 10(4):505-48. PubMed ID: 2243513
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of solid tumors.
    Alberto P
    Aktuelle Probl Chir; 1970; 14():807-34. PubMed ID: 4147168
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influencing the immune status of cancer patients through chemotherapy].
    Micksche M
    Wien Med Wochenschr; 1975 Dec; 125(50-52):729-35. PubMed ID: 779283
    [No Abstract]   [Full Text] [Related]  

  • 9. The present approach to systematic cancer therapy.
    Mukerjea DN; Koven BJ
    Indian J Cancer; 1970 Sep; 7(3):174-90. PubMed ID: 4927710
    [No Abstract]   [Full Text] [Related]  

  • 10. The need for additional alkylating agents and antimetabolites.
    Heidelberger C
    Cancer Res; 1969 Dec; 29(12):2435-42. PubMed ID: 4905240
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukemia: current concepts in therapy.
    LEIKIN SL
    Pediatr Clin North Am; 1962 Aug; 9():753-68. PubMed ID: 14463851
    [No Abstract]   [Full Text] [Related]  

  • 12. [PROBLEMS IN ACQUIRED RESISTANCE OF TUMORS TOWARDS CYTOSTATICS].
    UJHAZY V
    Bratisl Lek Listy; 1964; 44():562-8. PubMed ID: 14160201
    [No Abstract]   [Full Text] [Related]  

  • 13. Special microbiological systems. III. The use of lactic acid bacteria for the evaluation of purine and pyrimidine antagonists.
    HITCHINGS GH
    Ann N Y Acad Sci; 1958 Dec; 76(3):490-5. PubMed ID: 13627874
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy of advanced ovarian carcinoma with the antimetabolite, methotrexate, and the alkylating agent, thioTEPA.
    GREENSPAN EM; FIEBER M
    J Mt Sinai Hosp N Y; 1962; 29():48-62. PubMed ID: 13901566
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppression and chemotherapeutic agents.
    Kim Z
    Ann Allergy; 1981 Aug; 47(2):79-83. PubMed ID: 7258742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity to analogs of thiamine pyrimidine associated with resistance to amethopterin or purine antagonists.
    GUTHRIE R; LOEBECK ME; HILLMAN MJ
    Proc Soc Exp Biol Med; 1957 Apr; 94(4):792-4. PubMed ID: 13431959
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pyrimidine- and purine-type antimetabolites].
    Skoda J
    Cas Lek Cesk; 1972 Nov; 111(45):1060-1. PubMed ID: 5084854
    [No Abstract]   [Full Text] [Related]  

  • 18. Properties of purine and pyrimidine analogs.
    Hitchings GH
    Adv Enzyme Regul; 1991; 31():433-43. PubMed ID: 1877398
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanism of action of anti-leukemia agents and adverse effects].
    Nakamura T; Ueda T
    Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1033-9. PubMed ID: 1402252
    [No Abstract]   [Full Text] [Related]  

  • 20. CROSS RESISTANCE AND COLLATERAL SENSITIVITY STUDIES IN CANCER CHEMOTHERAPY.
    HUTCHISON DJ
    Adv Cancer Res; 1963; 7():235-50. PubMed ID: 14153767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.